C. Ansquer

1.6k total citations
59 papers, 943 citations indexed

About

C. Ansquer is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, C. Ansquer has authored 59 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 20 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Surgery. Recurrent topics in C. Ansquer's work include Neuroendocrine Tumor Research Advances (23 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Neuroblastoma Research and Treatments (13 papers). C. Ansquer is often cited by papers focused on Neuroendocrine Tumor Research Advances (23 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Neuroblastoma Research and Treatments (13 papers). C. Ansquer collaborates with scholars based in France, Canada and United States. C. Ansquer's co-authors include Françoise Kraeber‐Bodéré, Éric Mirallié, Caroline Bodet‐Milin, Thomas Carlier, Caroline Rousseau, D. Drui, Clément Bailly, Jacques Barbet, Christophe Leux and David Taïeb and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

C. Ansquer

54 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ansquer France 19 383 360 256 229 176 59 943
Massimo Castellani Italy 18 296 0.8× 225 0.6× 144 0.6× 141 0.6× 105 0.6× 77 843
Gaia Grassetto Italy 20 530 1.4× 432 1.2× 213 0.8× 366 1.6× 221 1.3× 78 1.4k
Hubert H. Chuang United States 19 340 0.9× 255 0.7× 88 0.3× 354 1.5× 101 0.6× 52 1.2k
Sotirios Chondrogiannis Italy 20 558 1.5× 396 1.1× 191 0.7× 339 1.5× 150 0.9× 89 1.3k
Gaetano Paone Switzerland 16 660 1.7× 267 0.7× 289 1.1× 230 1.0× 54 0.3× 74 1.2k
Soňa Balogová France 18 591 1.5× 481 1.3× 237 0.9× 495 2.2× 419 2.4× 57 1.6k
Renzo Mazzarotto Italy 20 353 0.9× 472 1.3× 532 2.1× 326 1.4× 133 0.8× 63 1.5k
Laure Michaud France 13 336 0.9× 196 0.5× 48 0.2× 269 1.2× 102 0.6× 31 774
Homer Macapinlac United States 10 466 1.2× 339 0.9× 294 1.1× 327 1.4× 84 0.5× 21 1.2k
Serkan Kuyumcu Türkiye 18 377 1.0× 218 0.6× 125 0.5× 501 2.2× 303 1.7× 66 1.0k

Countries citing papers authored by C. Ansquer

Since Specialization
Citations

This map shows the geographic impact of C. Ansquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ansquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ansquer more than expected).

Fields of papers citing papers by C. Ansquer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ansquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ansquer. The network helps show where C. Ansquer may publish in the future.

Co-authorship network of co-authors of C. Ansquer

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ansquer. A scholar is included among the top collaborators of C. Ansquer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ansquer. C. Ansquer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chouin, Nicolas, Séverine Marionneau‐Lambot, Sébastien Gouard, et al.. (2024). Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 730–743. 5 indexed citations
2.
García‐Carbonero, Rocio, Paula Jiménez‐Fonseca, Urbano Anido, et al.. (2024). 177Lu-edotreotide versus everolimus in patients with advanced neuroendocrine tumors of lung or thymic origin: The phase 3 randomized LEVEL, GETNE-T2217 trial.. Journal of Clinical Oncology. 42(16_suppl). TPS3177–TPS3177.
3.
Thuillier, Philippe, Danielle Benisvy, C. Ansquer, et al.. (2022). SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : What is the role of functional imaging and isotopic treatment?. Annales d Endocrinologie. 83(6). 401–406. 2 indexed citations
4.
Ansquer, C., Éric Mirallié, Anne‐Paule Gimenez‐Roqueplo, et al.. (2020). Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery. Cancers. 12(9). 2424–2424. 16 indexed citations
5.
Régenet, Nicolas, Alain Sauvanet, Fabrice Muscari, et al.. (2020). The value of 18F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study. Journal of Visceral Surgery. 157(5). 387–394. 8 indexed citations
6.
7.
Ansquer, C., et al.. (2019). Novel PET tracers: added value for endocrine disorders. Endocrine. 64(1). 14–30. 15 indexed citations
8.
Bossard, Céline, Philippe Moreau, C. Ansquer, et al.. (2017). Hot lungs, bitter cherry: intravascular lymphoma. QJM. 111(1). 53–54. 1 indexed citations
9.
Bailly, Clément, et al.. (2016). Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials. PLoS ONE. 11(7). e0159984–e0159984. 68 indexed citations
10.
Drui, D., et al.. (2016). Contribution of 18-FDG PET/CT to brown tumor detection in a patient with primary hyperparathyroidism. Joint Bone Spine. 84(2). 209–212. 17 indexed citations
11.
Blanchard, Claire, Muriel Mathonnet, F. Sébag, et al.. (2014). Quality of Life is Modestly Improved in Older Patients with Mild Primary Hyperparathyroidism Postoperatively: Results of a Prospective Multicenter Study. Annals of Surgical Oncology. 21(11). 3534–3540. 26 indexed citations
12.
Lintia-Gaultier, Alina, et al.. (2013). Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma. Nuclear Medicine Communications. 34(7). 674–681. 19 indexed citations
13.
Carlier, Thomas, Thomas Eugène, Caroline Bodet‐Milin, et al.. (2013). Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Research. 3(1). 11–11. 62 indexed citations
14.
Salaün, Pierre‐Yves, L. Campion, Claire Bournaud, et al.. (2012). Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement. Journal of Nuclear Medicine. 53(8). 1185–1192. 44 indexed citations
15.
Kraeber‐Bodéré, Françoise, Pierre‐Yves Salaün, C. Ansquer, et al.. (2012). Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC). Tumor Biology. 33(3). 601–606. 9 indexed citations
16.
Meurette, G., et al.. (2010). Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions. Gastroentérologie Clinique et Biologique. 34(8-9). 465–474. 25 indexed citations
17.
Mirallié, Éric, B. Bridji, I. Resche, et al.. (2007). Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma. Surgery. 142(6). 952–958. 54 indexed citations
18.
Oudoux, A., Pierre‐Yves Salaün, Claire Bournaud, et al.. (2007). Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy. The Journal of Clinical Endocrinology & Metabolism. 92(12). 4590–4597. 64 indexed citations
19.
Carlier, Thomas, Caroline Bodet‐Milin, Michel Defrise, et al.. (2006). Technical feasibility of pinhole SPECT acquisition in primary hyperparathyroidism: phantom and patient studies.. Open Repository and Bibliography (University of Liège). 1 indexed citations
20.
Lopès, Patrice, et al.. (2006). Intérêt de la technique de lymphadénectomie sélective dans les cancers de vulve. Gynécologie Obstétrique & Fertilité. 34(12). 1105–1110. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Castellani Breakdown of academic impact, for papers by Gaia Grassetto Breakdown of academic impact, for papers by Hubert H. Chuang Breakdown of academic impact, for papers by Sotirios Chondrogiannis Breakdown of academic impact, for papers by Gaetano Paone Breakdown of academic impact, for papers by Soňa Balogová Breakdown of academic impact, for papers by Renzo Mazzarotto Breakdown of academic impact, for papers by Laure Michaud Breakdown of academic impact, for papers by Homer Macapinlac Breakdown of academic impact, for papers by Serkan Kuyumcu
Rankless by CCL
2026